Thermo Fisher Scientific

Your educational resource for biopharma, pharma, environmental, food and agriculture, industrial, and clinical labs

Accelerating ScienceAnalyteGuru / Mass Spectrometry / Thermo Fisher Scientific at ICRAV 2026

Thermo Fisher Scientific at ICRAV 2026

By 02.27.2026

March 22 to 29, 2026 | Visit us at booth #28

Thermo Fisher Scientific is proud to be a Platinum sponsor at ICRAV 2026, bringing next generation mass spectrometry solutions to the forefront of anti-doping and analytical toxicology. We are showcasing integrated workflows designed to bridge research, innovation and routine laboratory excellence to support the challenges commonly observed during adverse analytical findings and subsequent confirmation.

ICRAV Melbourne 2026

Be sure to visit us at Booth #28 to explore our latest technologies, including the new Thermo Scientific TSQ Certis triple quadrupole mass spectrometer, and to learn how our portfolio supports confident, end to end analytical decision making.

Sponsored workshop

  • Saturday, 21st March | 8:00 AM to 5:00 PM | Bus departs: Crown Promenade, 8:00am
  • Location: Racing Analytical Services Limited (400 Epsom Road, Flemington Victoria 3031)
  • Speaker(s): Sean Yamada and the RASL R&D team
  • Title: Investigative Testing of Miscellaneous Samples
    • Objectives of investigative testing in the context of racing
    • Inspecting exhibits such as syringes, pills and powders
    • Choosing appropriate sample preparation methods based on objectives
    • Data acquisition and processing tools (targeted and untargeted analysis
    • Interpretation of results

During this program, Sean Yamada will highlight the application of Compound Discoverer software and advanced workflows using the Thermo Scientific IQ-X system to support metabolism investigations and broader testing strategies. Explore more information here: Workshops — ICRAV 2026

KOL presentation

  • Tuesday, March 24 | 8:30 to 10:30 AM
  • Location: Promenade Room 1 and 2
  • Speaker: Simon Hudson
  • Title: The Application of the New Thermo Fisher Stellar MS to Equine, Canine and Human Drug Testing

In this presentation, Simon Hudson will discuss the Thermo Scientific Stellar MS system, which combines triple quadrupole quantitative performance with ultra-fast polarity switching and high speed full scan MS2 and MSn acquisition using HCD or CID. He will share in house comparisons of existing HRAM and LC QQQ multi analyte screening methods for steroids, peptides, and drugs of abuse with methods developed on the Stellar system, highlighting improvements in throughput, sensitivity, selectivity, and laboratory efficiency.

Vendor presentation with Q&A

  • Wednesday, March 25 | 10:10 to 10:30 AM
  • Speaker: Edward Goucher, Thermo Fisher Scientific
  • Title: Adverse Analytical Findings: Bridging Research and Routine Workflows with Next Generation Mass Spectrometry

Adverse analytical findings require analytical workflows that balance speed, depth, and confidence from screening through confirmation. In this presentation, Ed Goucher will showcase integrated mass spectrometry strategies that unify targeted screening, combined quantitation and discovery, and confirmatory analysis within cohesive workflows.

Key topics include:

  • Tox Explorer targeted screening
    Rapid, high confidence detection of known compounds using the Thermo Scientific Orbitrap Exploris 120 MS platform.
  • SQUAD workflow, Simultaneous Quantitation and Discovery
    Combining targeted quantitation with untargeted metabolomics in a single experiment, enabling hypothesis driven analysis while preserving rich datasets for retrospective interrogation.
  • MSn on Stellar, screening and confirmation
    Emerging investigations into how the Thermo Scientific Stellar mass spectrometer enhances structural insight and analytical confidence through advanced fragmentation strategies.
  • TSQ Certis introduction
    Robust and selective quantitative confirmation of adverse analytical findings with the newest triple quadrupole platform from Thermo Fisher Scientific.

Together, these complementary workflows demonstrate how next generation mass spectrometry solutions support flexible, end to end strategies for confident decision making in anti doping laboratories.

Poster session

  • Date and time to be determined
  • Poster #6
  • Speaker: Edward Goucher, Thermo Fisher Scientific
  • Title: Selective and Sensitive Quantitation of 18 Steroids in Human Serum Using Thermo Scientific Stellar Mass Spectrometer

This study demonstrates how the hybrid quadrupole, dual pressure linear ion trap Stellar MS leverages combined CID /HCD and MSn scanning to enhance selectivity and sensitivity for steroid quantitation in complex serum matrices. Compared to conventional MS2 beam type CID approaches, alternative fragmentation strategies and MS3 acquisition improved limits of quantification for challenging analytes by 2 to 10 times, supporting high throughput, routine biomarker analysis.

This poster is the first to showcase how multiple collision activation modes and rapid MS2 and MS3 acquisition on Stellar MS can significantly improve selective quantitation of 18 steroids, highlighting the platform’s power in both research and routine settings.

Sponsored session

  • Wednesday, March 25 | 8:30 to 10:30 AM
  • Location: Promenade Room 1 and 2
  • Session: Metabolism Studies

Thermo Fisher Scientific is proud to support this comprehensive session focused on metabolism studies and its application in anti-doping science.

Featured presentations include:

  • Models for Simulating Mammalian Metabolism – Sean Yamada
  • Development of a 3D Equine Liver Model for Metabolic Studies Using an Organ-on-a-Chip Platform – Mario Thevis
  • Detection of Trazodone and its Metabolites in the Horse Following an Oral Administration – Marjaana Viljanto
  • Comprehensive Metabolic Investigation of Suzetrigine to Support Anti-Doping Strategies in Equestrian Sports – Shino Ann Koshy
  • Metabolites Identification of Non-Steroidal Selective Androgen Receptor Modulator PF-06260414 After Oral Administration in Thoroughbred Horses – Mahmoud MK Kamel Mohamed

Visit Booth #28

ICRAV 2026 is the ideal setting to explore how Thermo Fisher Scientific is advancing anti-doping and analytical workflows through:

Visit us at Booth #28 to connect with our team, see the newest technology in action, and discuss how we can support your laboratory from discovery to confirmation.

Explore more resources

Antidoping Analysis | Thermo Fisher Scientific – US

Visit us on LinkedIn: #certis #stellar #antidoping #ICRAV

Edward Goucher

Dr. Edward Goucher is a Senior Business Development Manager within the Chromatography & Mass Spectrometry Division at Thermo Fisher Scientific. He obtained his Ph.D. in Analytical Toxicology from King’s College London, UK, conducting research within the Pharmaceutical Science Research Division in collaboration with the London Drug Control Centre. Following his academic training, Dr. Goucher built extensive industry experience across analytical and commercial functions. His roles have included Laboratory Analyst at the London Drug Control Centre, Application Chemist, and Training Instructor, all of which have supported mass spectrometry workflow development and implementation . He has also held positions supporting commercial operations and strategic business initiatives. In his current role, Dr. Goucher supports vertical market strategy and product positioning activities, encompassing workflow development, portfolio management, global collaborations, marketing programs, and sales enablement. His work spans key segments including Clinical Research, Forensic and Sports Anti-Doping, Wellness and Personal Care, and Precision Medicine.